ENTITY
Sumitomo Pharma

Sumitomo Pharma (4506 JP)

70
Analysis
Health CareJapan
Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, as well as conducts clinical pathology tests for animals. Sumitomo Dainippon Pharma conducts businesses across worldwide.
more
Refresh
03 Jan 2019 08:40

Japan: 2018 Sector Review - Down, Down, Deeper & Down

DOWN, DOWN, DEEPER & DOWN - Japanese equities were as unfashionable as the venerable 'Quo' in 2018, although all of the year's decline...

Logo
625 Views
Share
21 Dec 2018 05:56

2018 Was Not the Year for Value or Beta Names in Japan....

We looked back and identified which factors drove the Japanese market in 2018. We found that Value, which is historically strong in Japan, did...

Logo
999 Views
Share
18 Dec 2018 14:43

Japan Pharma - Top Picks

While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP)  is a contrarian call in anticipation of value...

17 Dec 2018 08:01

Japan: Fortnightly Update - And So It Goes

AND SO IT GOES - After our eight-day 4.5% 'Thanksgiving rally', the market reverted to recent type and promptly fell 6.5% to Tuesday's low, which...

Logo
423 Views
Share
09 Dec 2018 18:43

Japan: Moving Average Outliers - Market, Sectors & Stocks - Hoshizaki, Sumco & Sharp

MARKET COMPOSITEMARKET MOVING AVERAGES - As a prelude to our usual review of stock moving average outliers, we shall look at the current trend in...

Logo
391 Views
Share
x